FOXP3 expression and TSDR demethylation have been widely used as prognostic markers for determining the proportion of Treg cells in peripheral blood from healthy individuals and in certain diseases such as ovary, breast and colorectal cancers and other solid tumors (34, 35). The gene discussed is FOXP3; the disease is colorectal cancer.